Replies to post #94753 on Innovation Pharmaceuticals Inc (IPIX)

[keltoi]

Very well said.Thanks for posting it.

Kelt

[BobbyKIrk]

Karin were are we at for P ? maybe you have all the answers . how about BOM or board of directors . Thank you bobby

[havendale]

Agreed Karin, given the size of the company, the size of the staff, the resources and the money, I think Leo should be applauded for what has been accomplished and what will be accomplished.

[I Need Help]

Karin, your observations are spot on. Good to remind us; that, biotech advances can be a slow, slow process. Stocks will have their cycles.

One person's winner, another's loser. Timing.

Also, time horizon: Sell today and take a loss, hold for the long term for a profit (vice versa too). Timing (technical), and fundamental analysis.

Love your articulation of some tried and trued basics. Your post:

This board is followed by 573 people, most of whom only read. Information both pro and con is found valuable to most people. The key is accuracy. Negative information is extraordinarily valuable for investors if accurate. Inaccurate information is what most don't like.

Whether pro or con info is presented, one must do their own due diligence to verify it. With time you'll get a sense for which posters generally give correct or incorrect info.

It's also obvious that there are quite a few invested here that don't understand the nature of biotech.

Biotech is not only risky, but, it is regularly subject to time delays. Leo isn't perfect and hasn't done everything the way I'd like, but, overall, he's done a terrific job. Just look at the decision to postpone Prurisol in order to pick up the Polymedix assets. That took b@lls. The majority of shareholders that were vocal were very upset at the time. Yet, with the passage of time the decision can be seen to be an excellent one. We'd be under a dollar without Brilacidin now. Most wouldn't have had patience for the pace of the Kevetrin phase 1 oncology trial at Dana Farber.

Brilacidin's phase 2b ABSSSI trial has derisked Cellceutix substantially for me. I'm just sitting and holding. I expect to do so for years, thus, my lack of fear for how it is trading now. I suppose, if I were day trading I might view things differently.

[winnail]

As usual,well put Karin.

[alwaysdreaming]

On a scale of 1 to 10 Karin, having the PR yesterday, caused a traders paradise at a 10, or a loser at 1?

[chrisrobert]

Agreed KarinCA, I am one of those that usually just reads. I know very little about biotech however I find CTIX to be very promising. I think, while not perfect, Leo has done a fantastic job thus far. I also feel that B has the potential to be a true blockbuster and has derisked Cellceutix. B was the original reason I started buying into CTIX. The potential for B can't be overstated.

I find it interesting when posters suggest that uplisting is the way to improve value. Uplisting would also open a thinly traded stock to large scale short selling and options trading as well as margin buying so I am not sure it is the panacea some are expecting. There are many biotechs available already on other exchanges so if that is what an investor desires why not go with one that is already there? The drive up in stock price will come from science, solid management, good decisions and milestone achievements.

One last point, you hit the nail on the head! After following this board for over a year I know there are some that provide great information and some that are just blowing smoke. Thanks for being such a valuable, insightful and informative poster on this forum. I learned much from you and a few others on this board as well. For what it's worth I originally bought into CTIX after reading about Cellceutix and Brilacidan on SA then following up on here and some additional due diligence. I am up over 75% so no complaints and I plan to continue to accumulate shares.